Overview

Dinalbuphine Sebacate in Postoperative Pain Control After TKA

Status:
NOT_YET_RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of Dinalbuphine Sebacate for controlling subacute pain after total knee arthroplasty
Phase:
PHASE4
Details
Lead Sponsor:
Thammasat University
Treatments:
Saline Solution